GlassScriptPhysician profile
Bridget Virginia Reddington
NPI 1679212351
$529.18
in general payments reported to CMS, 2019-2025
17 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $131 · 2024: $148 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $529.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $111.68 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Abbvie INC. | $52.22 | 2023-2025 | |
| Taiho Oncology, INC. | $42.57 | 2024-2025 | |
| Eisai INC. | $38.60 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $37.99 | 2024-2025 | Enhertu, Calquence |
| Caris Mpi, INC. | $25.92 | 2025 | Mi Cancer Seek |
| Daiichi Sankyo INC. | $24.90 | 2024 | Enhertu |
| Amgen INC. | $24.15 | 2023 | Lumakras |
| Bayer Healthcare Pharmaceuticals INC. | $23.81 | 2024 | |
| Mirati Therapeutics, INC. | $20.11 | 2024 | Krazati |
| Pharmacosmos Therapeutics INC. | $19.65 | 2025 | Monoferric |
| Novartis Pharmaceuticals Corporation | $19.57 | 2025 | |
| Astellas Pharma US INC | $18.95 | 2023 | Xospata |
| Deciphera Pharmaceuticals INC. | $17.81 | 2025 | Tgct, Qinlock |
| Genentech USA, INC. | $17.42 | 2023 | Venclexta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $17.01 | 2025 | Alymsys |
| Jazz Pharmaceuticals INC. | $16.82 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridget Reddington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.